Monitoring the sensitivity of influenza viruses to oseltamivir, in Romania, from 2016 to 2023

1 https://insp.gov.ro/download/metodologia-de-supravegheregripa-infectii-respiratorii-acute-si-sari-2021-2022_actualizare-12-octombrie-2021-pdf/?wpdmdl=96151&refresh=658d40155f8641703755797 Search in Google Scholar

2 Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza 2011. Geneva, WHO. Search in Google Scholar

3 Kikuchi C, Antonopoulos A, Wang S, Maemura T, Karamanska R, Lee C, et al. Glyco-engineered MDCK cells display preferred receptors of H3N2 influenza absent in eggs used for vaccines. Nat Commun. 2023 Oct 4;14(1):6178. DOI: 10.1038/s41467-023-41908-0 Search in Google Scholar

4 NISN IC50 Methodology (http://www.nisn.org/) Search in Google Scholar

5 Aifeng Li, Weihong W, Wenfang X, Jianzhi G. A microplate-based screening assay for neuraminidase inhibitors. Drug Discov Ther. 2009; 3(6):260-5. Search in Google Scholar

6 https://isirv.org/site/index.php/methodology/nai-assay-ic50 Search in Google Scholar

7 Meetings of the WHO working group on surveillance of influenza antiviral susceptibility - Geneva, November 2011 and June 2012. Weekly epidemiological record. 2012;87(39):369-74. Search in Google Scholar

8 Okomo-Adhiambo M, Nguyen HT, Abd Elal A, Sleeman K, Fry AM, Gubareva LV. Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria. Influenza Other Respir Viruses. 2014 Mar;8(2):258-65. DOI: 10.1111/irv.12215 Search in Google Scholar

9 Wong S, Pabbaraju K, Wong A, Fonseca K, Drews SJ. Development of a real-time RT-PCR assay for detection of resistance to oseltamivir in influenza A pandemic (H1N1) 2009 virus using single nucleotide polymorphism probes. J Virol Methods. 2011 May;173(2):259-65. DOI: 10.1016/j.jviromet.2011.02.014 Search in Google Scholar

10 van der Vries E, Anber J, van der Linden A, Wu Y, Maaskant J, Stadhouders R, van Beek R, Rimmelzwaan G, Osterhaus A, Boucher C, Schutten M. Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutations. J Mol Diagn. 2013 May;15(3):347-54. DOI: 10.1016/j. jmoldx.2012.11.007 Search in Google Scholar

11 Necula G, Mihai ME, Sbarcea CE, Dinu S, Lupulescu E, Ceausu E, et al. Overview of influenza virus antiviral resistance in Romania in the last four epidemic seasons - phenotyping, genotyping and molecular analysis study. Rev Romana Med Lab. 2011;19(3):227-40. Search in Google Scholar

12 European Centre for Disease Prevention and Control. Influenza virus characterization, summary Europe, June 2017. Stockholm: ECDC; https://www.ecdc.europa.eu/en/publications-data/influenza-virus-characterisation-summary-europe-june-2017 Search in Google Scholar

13 European Centre for Disease Prevention and Control. Influenza virus characterization, summary Europe, July 2018. Stockholm: ECDC; https://www.ecdc.europa.eu/en/publications-data/influenza-virus-characterisation-summary-europe-july-2018 Search in Google Scholar

14 European Centre for Disease Prevention and Control. Influenza virus characterization, summary Europe, July 2020. Stockholm: ECDC; https://www.ecdc.europa.eu/en/publications-data/influenza-virus-characterisation-summary-europe-july-2020 Search in Google Scholar

15 Takashita E, Kiso M, Fujisaki S, Yokoyama M, Nakamura K, Shirakura M, et al. Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan. Antimicrob Agents Chemother. 2015 May;59(5):2607-17.. DOI: 10.1128/AAC.04836-14 Search in Google Scholar

16 Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Gehrig N, Kelso A. Community transmission of oseltamivir-resistant A(H1N1) pdm09 influenza. N Engl J Med. 2011 Dec 29;365(26):2541-2. DOI: 10.1056/NEJMc1111078 Search in Google Scholar

17 Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Leang SK, et al. Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis. 2012 Jul 15;206(2):148-57. DOI: 10.1093/infdis/jis337 Search in Google Scholar

18 Bragstad K, Hungnes O, Litleskare I, Nyrerød HC, Dorenberg DH, Hauge SH. Community spread and late season increased incidence of oseltamivir-resistant influenza A(H1N1) viruses in Norway 2016. Influenza Other Respir Viruses. 2019 Jul;13(4):372-381. DOI: 10.1111/irv.12637 Search in Google Scholar

19 Abed Y, Pizzorno A, Bouhy X, Boivin G. Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains. Antiviral Res. 2015;114:57-61. DOI: 10.1016/j.antiviral.2014.12.006 Search in Google Scholar

20 Butler J, Hooper KA, Petrie S, Lee R, Maurer-Stroh S, Reh L, et al. Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses. PLoS Pathog. 2014 Apr 3;10(4):e1004065. DOI: 10.1371/journal.ppat.1004065 Search in Google Scholar

21 Groves HE, Piché-Renaud PP, Peci A, Farrar DS, Buckrell S, Bancej C, Sevenhuysen C, Campigotto A, Gubbay JB, Morris SK. The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: A population-based study. Lancet Reg Health Am. 2021 Sep;1:100015. DOI: 10.1016/j.lana.2021.100015 Search in Google Scholar